You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Pregnancy and Breast Feeding
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Infectious Diseases
 •Alert me on articles by topic

Hepatitis B Maternal Screening, Infant Vaccination, and Infant Prophylaxis Practices in North Carolina

Richard L. Pierce, MPH, PhD; Sheree Smith, RN, BSN; Beth Rowe-West, RN, BSN; Barbara Sterritt, RN, MSN

Arch Pediatr Adolesc Med. 1999;153:619-623.

Objectives  To determine if the Advisory Committee on Immunization Practices hepatitis B screening, vaccination, and prophylaxis recommendations were being followed in North Carolina, and to establish a baseline hepatitis B seroprevalence rate.

Design  A survey of mother and infant birthing facility medical records.

Setting  Four birthing facilities selected from each of the 7 districts in North Carolina (a total of 28 facilities).

Participants  A probability proportional to size survey design was used to select 4763 mother-infant record pairs. All records came from the 1996 birth cohort.

Main Outcome Measures  Maternal hepatitis B screening status, infant vaccination status, infants prophylaxis status, hepatitis B seroprevalence rate, demographic and clinical predictors for maternal infection, failure to receive prenatal care or for whom status was unknown, failure to screen, and failure to vaccinate.

Results  Ninety-two percent of pregnant women were screened for hepatitis B surface antigen. Eighty-six percent of infants received dose 1 of the hepatitis B vaccine. Four of the 9 infants with mothers who were hepatitis B surface antigen–positive did not receive both vaccine and hepatitis B immune globulin. The hepatitis B seroprevalence rate was 0.2%. Mothers who were not screened for infection were 3.4 times more likely to have infants who were not vaccinated. White mothers were twice as likely not to have their child vaccinated as mothers of other races.

Conclusions  Not all infants with hepatitis B–infected mothers were receiving vaccine and hepatitis B immune globulin as recommended. Seroprevalence of hepatitis B infection may be lower in North Carolina than in other states. Hepatitis B laboratory test results should be included in every mother's medical record.


From the North Carolina Division of Women and Children's Health, Immunization Section, Raleigh.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

RE: "TEN LARGEST RACIAL AND ETHNIC HEALTH DISPARITIES IN THE UNITED STATES BASED ON HEALTHY PEOPLE 2010 OBJECTIVES"
Chang and So
Am J Epidemiol 2007;166:1105-1106.
FULL TEXT  

Assessment of Screening, Treatment, and Prevention of Perinatal Infections in the Philadelphia Birth Cohort
Jessop et al.
American Journal of Medical Quality 2005;20:253-261.
ABSTRACT  

Impact of the Thimerosal Controversy on Hepatitis B Vaccine Coverage of Infants Born to Women of Unknown Hepatitis B Surface Antigen Status in Michigan
Biroscak et al.
Pediatrics 2003;111:e645-649.
ABSTRACT | FULL TEXT  

Hepatitis B Vaccine Administration and Communication Policies in Rural Colorado Hospitals
Brayden et al.
CLIN PEDIATR 2000;39:723-726.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.